Core Points - On November 27, Bibete's stock rose by 2.57% with a trading volume of 426 million yuan [1] - The financing data indicates that Bibete had a financing buy amount of 34.91 million yuan and a financing repayment of 45.09 million yuan, resulting in a net financing buy of -10.18 million yuan [1] - As of November 27, the total balance of margin trading for Bibete was 91.90 million yuan, which accounts for 5.98% of its market capitalization [1] Financing Summary - On the same day, Bibete's financing buy was 34.91 million yuan, while the current financing balance stands at 91.90 million yuan [1] - The financing balance represents 5.98% of the company's circulating market value [1] Securities Lending Summary - On November 27, Bibete had no shares repaid or sold in the securities lending market, resulting in a sell amount of 0.00 yuan [1] - The securities lending balance and remaining shares were both recorded at 0.00 [1] Company Overview - Bibete Pharmaceutical Co., Ltd. is located in the Science City of Guangzhou, Guangdong Province, and was established on January 19, 2012, with a listing date set for October 28, 2025 [1] - The company focuses on the independent research and development of innovative drugs [1] Shareholder Information - As of November 10, Bibete had 24,000 shareholders, a decrease of 50.05% from the previous period [1] - The average number of circulating shares per shareholder increased by 100.21% to 1,938 shares [1] Financial Performance - For the period from January to September 2025, Bibete reported an operating income of 0.00 yuan and a net profit attributable to the parent company of -107 million yuan [1]
必贝特11月27日获融资买入3491.37万元，融资余额9189.84万元